NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib
NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib
Buyer
NHS England
Value
£17,300,000
Published
11 Mar 2021
Closes
8 Dec 2020
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
15 Jan 2021
Contract ends
31 Oct 2021
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib
£17,300,000
NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
11 Mar 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
Document No. 03 - Framework Agreement and Terms and Conditions
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions
Link
Parties Appointed to the Framework - NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib
Not provided
Parties Appointed to the Framework - NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib
Link
Transparency Award Schedule - NHS National Pharmaceuticals - Fulvestrant and Darunavir
Not provided
Transparency Award Schedule - NHS National Pharmaceuticals - Fulvestrant and Darunavir
Link
Transparency Award Schedule - NHS National Pharmaceuticals - Imatinib
Not provided
Transparency Award Schedule - NHS National Pharmaceuticals - Imatinib
Link
Contains public sector information licensed under the Open Government Licence v3.0.